5 research outputs found
Recommended from our members
Desalination of brackish ground waters and produced waters using in-situ precipitation.
The need for fresh water has increased exponentially during the last several decades due to the continuous growth of human population and industrial and agricultural activities. Yet existing resources are limited often because of their high salinity. This unfavorable situation requires the development of new, long-term strategies and alternative technologies for desalination of saline waters presently not being used to supply the population growth occurring in arid regions. We have developed a novel environmentally friendly method for desalinating inland brackish waters. This process can be applied to either brackish ground water or produced waters (i.e., coal-bed methane or oil and gas produced waters). Using a set of ion exchange and sorption materials, our process effectively removes anions and cations in separate steps. The ion exchange materials were chosen because of their specific selectivity for ions of interest, and for their ability to work in the temperature and pH regions necessary for cost and energy effectiveness. For anion exchange, we have focused on hydrotalcite (HTC), a layered hydroxide similar to clay in structure. For cation exchange, we have developed an amorphous silica material that has enhanced cation (in particular Na{sup +}) selectivity. In the case of produced waters with high concentrations of Ca{sup 2+}, a lime softening step is included
Recommended from our members
Nanofiltration treatment options for thermoelectric power plant water treatment demands.
Testosterone and obesity
Testosterone is a key hormone in the pathology of metabolic diseases such as obesity. Low testosterone levels are associated with increased fat mass (particularly central adiposity) and reduced lean mass in males. These morphological features are linked to metabolic dysfunction, and testosterone deficiency is associated with energy imbalance, impaired glucose control, reduced insulin sensitivity and dyslipidaemia. A bidirectional relationship between testosterone and obesity underpins this association indicated by the hypogonadal–obesity cycle and evidence weight loss can lead to increased testosterone levels. Androgenic effects on enzymatic pathways of fatty acid metabolism, glucose control and energy utilization are apparent and often tissue specific with differential effects noted in different regional fat depots, muscle and liver to potentially explain the mechanisms of testosterone action. Testosterone replacement therapy demonstrates beneficial effects on measures of obesity that are partially explained by both direct metabolic actions on adipose and muscle and also potentially by increasing motivation, vigour and energy allowing obese individuals to engage in more active lifestyles. The degree of these beneficial effects may be dependent on the treatment modality with longer term administration often achieving greater improvements. Testosterone replacement may therefore potentially be an effective adjunctive treatment for weight management in obese men with concomitant hypogonadism